Company Performance Metrics
APRILIS is engaged in the development of an advanced diagnostic kit for identifying antibiotic resistance in super bacteria. APRILIS initially operated as a dedicated distributor of the Auto-Chek® blood glucose monitor designed for home use since 2013. Presently, APRILIS is focused on creating effective tools for managing chronic diseases. They are
actively developing various components such as diet management, advanced nutrition analysis utilizing Deep Learning, prediction of glycemic hemoglobin, and diabetic complication anticipation. In addition, APRILIS is working on an integrated application system that includes platform services for home medical devices like blood glucose monitors, blood pressure monitors, body fat analyzers, and smart bands.